Cancer Research, Statistics, and Treatment (Jan 2020)
A commentary on outcomes with liquid biopsy to determine the epidermal growth factor receptor mutation status in poor performance status, biopsy-ineligible, advanced non-small cell lung cancer patients
Abstract
No abstracts available.